Knowledge, Preference, and Adverse Effects of Xylazine Among Adults in Substance Use Treatment

JAMA Netw Open. 2024 Feb 5;7(2):e240572. doi: 10.1001/jamanetworkopen.2024.0572.

Authors

Martin Hochheimer¹, Justin C Strickland¹, Jill A Rabinowitz², Jennifer D Ellis¹, Kelly E Dunn¹, Andrew S Huhn¹

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey.

No abstract available

Plain language summary

This cross-sectional study evaluates aspects of xylazine adulteration of opioids among individuals entering substance use disorder treatment.

MeSH terms

Adult
Drug-Related Side Effects and Adverse Reactions*
Humans
Iatrogenic Disease
Knowledge
Substance-Related Disorders* / epidemiology
Xylazine

Substances

Xylazine